ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Free Report) – Stock analysts at Leerink Partnrs lifted their Q4 2024 earnings per share estimates for ACADIA Pharmaceuticals in a research report ...
Dover Corporation reported Q4 results with revenue at $1.930B, up 1% Y/Y but missed consensus. Company expects margin improvement in 2025 with double-digit EPS growth.
Reports Q4 tangible book value per share $42.93. Tompkins President and CEO, Stephen Romaine, commented, “We are pleased to report increased earnings for the year and fourth quarter of 2024.
CEO Damian Kozlowski reported Q4 EPS of $1.15 and full-year EPS of $4.29, reflecting year-over-year increases of 41% and 23%, respectively. Total revenue increased 8%, excluding $19.6 million of ...